Botox and Jeuveau are both FDA-approved botulinum toxin type A injectables that smooth dynamic wrinkles with similar efficacy and onset timelines. The choice between them hinges on cost structure, patient acquisition strategy, and loyalty positioning rather than clinical outcomes.
Efficacy & Mechanism: Essentially Equivalent
Both products work identically: they block acetylcholine release at the neuromuscular junction, relaxing muscles that cause frown lines, forehead wrinkles, and crow's feet. Results appear in 3–7 days, peak at 2 weeks, and last 3–4 months. Patient satisfaction rates are comparable, and resistance development is rare with either product.
Pricing & Profit Margins
Botox (Allergan/AbbVie) typically carries a higher wholesale cost but benefits from decades of brand recognition and patient demand. Many patients specifically request it by name.
Jeuveau (Evolus) launched in 2019 with aggressive pricing to capture market share. It often costs 15–25% less wholesale than Botox, allowing you to either undercut competitor pricing or maintain similar retail prices with higher margins.
Verify current wholesale pricing with your distributor, as rebate programs and volume discounts shift seasonally.
Patient Positioning & Loyalty
Botox dominates brand awareness. Offering it alone signals premium positioning and may attract patients who won't consider alternatives.
Compared
Botox
Jeuveau
Mechanism
Botulinum toxin type A; blocks acetylcholine at neuromuscular junction
Botulinum toxin type A; blocks acetylcholine at neuromuscular junction
Onset
3–7 days; peaks at 2 weeks
3–7 days; peaks at 2 weeks
Typical duration
3–4 months
3–4 months
Efficacy & patient satisfaction
Comparable; rare resistance development
Comparable; rare resistance development
Wholesale cost basis
Higher; premium brand positioning
15–25% lower; aggressive pricing strategy
Margin flexibility
Premium pricing; limited margin upside
Lower cost allows undercut pricing or higher margins
Patient positioning
Dominant brand awareness; premium market appeal
Newer option; price-conscious and value-seeking patients
Bottom line: Choose Botox for affluent, brand-loyal markets; choose Jeuveau for margin flexibility and price-conscious patients—or offer both to capture wider demographics and reduce revenue risk.
Jeuveau costs 15–25% less wholesale than Botox, letting you undercut competitors or boost margins while delivering identical results.
Jeuveau appeals to price-conscious patients and those seeking a "newer" option. Some practices offer both, positioning Jeuveau as an equally effective value choice—this can convert price-sensitive prospects and reduce patient defection to competitors.
Practical Considerations for Owners
Single-product strategy: Simpler inventory, staff training, and marketing. Botox alone is defensible if your market supports premium pricing.
Dual-product strategy: Requires separate inventory, slightly more staff education, and dual marketing. Benefit: capture a wider price-point demographic and reduce patient churn.
Rewards programs: Both products integrate into loyalty/point systems. Jeuveau's lower cost can fund more aggressive rewards without eroding margins.
Regulatory & supply: Both are stable, FDA-approved, and widely available. No meaningful regulatory advantage to either.
Bottom Line
Choose Botox if your market is affluent or brand-loyal. Choose Jeuveau if you want margin flexibility or need to compete on price. Many successful practices offer both—it's a low-friction way to serve different patient segments and protect revenue if one product faces supply disruption.
Frequently asked questions
Is Jeuveau as effective as Botox?
Yes, both are FDA-approved botulinum toxin type A products with identical mechanisms and comparable efficacy. Results appear in 3–7 days, peak at 2 weeks, and last 3–4 months for both, with similar patient satisfaction rates and rare resistance development.
How much cheaper is Jeuveau than Botox wholesale?
Jeuveau typically costs 15–25% less wholesale than Botox, allowing practices to either undercut competitor pricing or maintain similar retail prices with higher profit margins. Exact pricing varies by distributor and volume discounts.
Should my medspa offer both Botox and Jeuveau?
A dual-product strategy lets you serve price-sensitive and premium-seeking patients, reducing churn and capturing wider market segments. The trade-off is slightly higher inventory and staff training; a single-product approach is simpler but may limit your addressable market.
Do patients specifically request Botox by name?
Yes, Botox dominates brand awareness due to decades of marketing, and many patients specifically request it by name. Offering it alone can signal premium positioning, though Jeuveau appeals to cost-conscious patients and those seeking newer alternatives.
Can I use Jeuveau in loyalty and rewards programs?
Yes, both Botox and Jeuveau integrate into loyalty and point systems. Jeuveau's lower wholesale cost makes it easier to fund more aggressive rewards programs without eroding your margins.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
